In whole blood from stroke patients, the activation markers CD25, CTLA-4, and PD-L1 were quantified on CD4+ or CD8+ T cells at 3 days (t1), 1 month (t2), and 3 months (t3) post stroke and compared to old as well as young controls for age effects. The gene discussed is CD4; the disease is stroke disorder.